https://www.selleckchem.com/pr....oducts/geneticin-g41
In the postacute setting, beneficiaries who received care at top-recommended SNFs had a relative reduction of 37% for emergent care and 36% for inpatient hospitalization due to respiratory infection. Precision management through personalized and predictive ML offers the opportunity to reduce the burden of outbreaks of respiratory infections. In the community setting, ML can identify vulnerable subpopulations at highest risk of severe infections. In postacute settings, ML can inform patient choices by matching beneficiarie